McInerney Marcia F, Najjar Sonia M, Brickley Deanna, Lutzke Mary, Abou-Rjaily George A, Reifsnyder Peter, Haskell Bradford D, Flurkey Kevin, Zhang Ying-Jian, Pietropaolo Susan L, Pietropaolo Massimo, Byers James P, Leiter Edward H
Department of Medicinal and Biological Chemistry, University of Toledo College of Pharmacy, Toledo, OH 43606, USA.
Exp Diabesity Res. 2004 Jul-Sep;5(3):177-85. doi: 10.1080/15438600490478029.
The New Zealand obese (NZO) mouse strain shares with the related New Zealand black (NZB) strain a number of immunophenotypic traits. Among these is a high proportion of B-1 B lymphocytes, a subset associated with autoantibody production. Approximately 50% of NZO/HlLt males develop a chronic insulin-resistant type 2 diabetes syndrome associated with 2 unusual features: the presence of B lymphocyte-enriched peri-insular infiltrates and the development of anti-insulin receptor autoantibodies (AIRAs). To establish the potential pathogenic contributions of B lymphocytes and AIRAs in this model, a disrupted immunoglobulin heavy chain gene (Igh-6) congenic on the NZB/BlJ background was backcrossed 4 generations into the NZO/HlLt background and was then intercrossed to produce mice that initially segregated for wild-type versus the mutant Igh-6 allele and thus permitted comparison of syndrome development. A new flow cytometric assay (AIRA binding to transfected Chinese hamster ovary cells stably expressing mouse insulin receptor) showed IgM and IgG subclass AIRAs in serum from Igh-6 intact males, but not in Igh-6null male serum. However, the absence of B lymphocytes and antibodies distinguishing mutant from wild-type males failed to significantly affect diabetes-free survival. The Igh-6null males gained weight less rapidly than wild-type males, probably accounting for a retardation, but not prevention, of hyperglycemia. Thus, AIRA and the B-lymphocyte component of the peri-insulitis in chronic diabetics were not essential either to development of insulin resistance or to eventual pancreatic beta cell failure and loss. A new substrain, designated NZL, was generated by inbreeding Igh-6 wild-type segregants. Currently at the F10 generation, NZL mice exhibit the same juvenile-onset obesity as NZO/HlLt males, but develop type 2 diabetes at a higher frequency (> 80%). Also, unlike NZO/HlLt mice that are difficult to breed, the NZL/Lt strain breeds well and thus offers clear advantages to obesity/diabetes researchers.
新西兰肥胖(NZO)小鼠品系与相关的新西兰黑(NZB)品系具有许多免疫表型特征。其中包括高比例的B-1 B淋巴细胞,这是一个与自身抗体产生相关的亚群。大约50%的NZO/HlLt雄性小鼠会发展出一种慢性胰岛素抵抗型2糖尿病综合征,该综合征有两个不同寻常的特征:富含B淋巴细胞的胰岛周围浸润以及抗胰岛素受体自身抗体(AIRA)的产生。为了确定B淋巴细胞和AIRA在该模型中的潜在致病作用,将在NZB/BlJ背景上的一个破坏的免疫球蛋白重链基因(Igh-6)回交4代到NZO/HlLt背景中,然后进行杂交以产生最初因野生型与突变型Igh-6等位基因而分离的小鼠,从而可以比较综合征的发展情况。一种新的流式细胞术检测方法(AIRA与稳定表达小鼠胰岛素受体的转染中国仓鼠卵巢细胞结合)显示,Igh-6完整的雄性小鼠血清中有IgM和IgG亚类的AIRA,但Igh-6缺失的雄性小鼠血清中没有。然而,B淋巴细胞的缺失以及区分突变型和野生型雄性小鼠的抗体缺失并未显著影响无糖尿病生存期。Igh-6缺失的雄性小鼠体重增加速度比野生型雄性小鼠慢,这可能是导致高血糖延迟出现的原因,但并非预防因素。因此,AIRA以及慢性糖尿病患者胰岛周围炎中的B淋巴细胞成分对于胰岛素抵抗的发展或最终胰腺β细胞功能衰竭和丧失并非必不可少。通过对Igh-6野生型分离株进行近亲繁殖产生了一个新的亚系,命名为NZL。目前处于F10代,NZL小鼠表现出与NZO/HlLt雄性小鼠相同的幼年起病型肥胖,但2型糖尿病的发病率更高(>80%)。此外,与难以繁殖的NZO/HlLt小鼠不同,NZL/Lt品系繁殖良好,因此为肥胖/糖尿病研究人员提供了明显的优势。